Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Ferroportin 1 (FPN1) is transmembrane protein involved in iron homeostasis. In the duodenum, FPN1 localizes to the basolateral surface of enterocytes where it appears to export iron out of the cell and into the portal circulation. FPN1 is also abundantly expressed in reticuloendothelial macrophages of the liver, spleen, and bone marrow, suggesting that this protein serves as an iron exporter in cells that recycle iron from senescent red blood cells. To directly test the hypothesis that FPN1 functions in the export of iron after erythrophagocytosis, FPN1 was stably expressed in J774 mouse macrophages by using retroviral transduction, and release of 59 Fe after phagocytosis of 59 Fe-labeled rat erythrocytes was measured. J774 cells overexpressing FPN1 released 70% more 59 Fe after erythrophagocytosis than control cells, consistent with a role in the recycling of iron from senescent red cells. Treatment of cells with the peptide hormone hepcidin, a systemic regulator of iron metabolism, dramatically decreased FPN1 protein levels and significantly reduced the efflux of 59 Fe after erythrophagocytosis. Subsequent fractionation of the total released 59 Fe into heme and nonheme compounds revealed that hepcidin treatment reduced the release of nonheme 59 Fe by 50% and 25% from control and FPN1-overexpressing cells, respectively, but did not diminish efflux of 59 Fe-heme. We conclude that FPN1 is directly involved in the export of iron during erythrocyte-iron recycling by macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FPN also enables iron recycling from hepatocytes and macrophages 5 .”
From Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“that acts in part as a negative regulator of iron efflux [328] by causing the internalisation of ferroportin [329-333].”
In the citing paper
“Macrophages and Kupffer cells scavenge heme from damaged or aged RBCs in the bone marrow, liver and spleen, and extract the Fe2+ iron using HO-1 and then either exports it back into the circulation through FPN or stores it in ferritin intracellularly (Knutson et al., 2005; Theurl et al., 2016).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Knutson et al., 2005
In the citing paper
“Frataxin is a nuclear-encoded mitochondrial protein conserved from yeast to human (166), but with no homology with proteins of known functional domains.”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [166]
In the citing paper
“The frataxin gene exhibits tissue-specific expression, with its mRNA most abundant in the heart, followed by the liver and skeletal muscle (166).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Iron-Source Preference of Staphylococcus aureus Infections
Skaar, E. P., Humayun, M., Bae, T., DeBord, K. L., & Schneewind, O. (2004) · Science · doi:10.1126/science.1099930 · Cited by 440
Identification of a Human Heme Exporter that Is Essential for Erythropoiesis
Quigley, J. G., Yang, Z., Worthington, M. T., Phillips, J. D., Sabo, K. M., Sabath, D. E., Berg, C. L., Sassa, S., Wood, B. L., & Abkowitz, J. L. (2004) · Cell · doi:10.1016/j.cell.2004.08.014 · Cited by 430
Hunter, H. N., Fulton, D. B., Ganz, T., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205305200 · Cited by 400
Perspectives in Iron Metabolism
Finch, C. A., & Huebers, H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062504 · Cited by 391
Pietrangelo, A. (2004) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2003.08.003 · Cited by 383
Iron Metabolism in the Reticuloendothelial System
Knutson, M., & Wessling-Resnick, M. (2003) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/713609210 · Cited by 355
Self-citationConstitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
Nicolas, G., Viatte, L., Lou, D.-Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C., & Vaulont, S. (2003) · Nature Genetics · doi:10.1038/ng1150 · Cited by 311
Ferritin Synthesis in Inflammation: I. PATHOGENESIS OF IMPAIRED IRON RELEASE
Konijn, A. M., & Hershko, C. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb08758.x · Cited by 251
Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages
Knutson, M. D., Vafa, M. R., Haile, D. J., & Wessling-Resnick, M. (2003) · Blood · doi:10.1182/blood-2003-04-1250 · Cited by 227
Self-citationRegulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation
Yang, F., Liu, X.-B., Quinones, M., Melby, P. C., Ghio, A., & Haile, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201485200 · Cited by 197
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression
Lymboussaki, A., Pignatti, E., Montosi, G., Garuti, C., Haile, D. J., & Pietrangelo, A. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00408-2 · Cited by 178
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X. A., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215686 · Cited by 158
Fillet, G., Beguin, Y., & Baldelli, L. (1989) · Blood · doi:10.1182/blood.v74.2.844.844 · Cited by 144
Iron metabolism in the erythrophagocytosing Kupffer cell
Kondo, H. G., Saito, K., Grasso, J. P., & Aisen, P. (1988) · Hepatology · doi:10.1002/hep.1840080108 · Cited by 125
Transmembrane movement of heme.
Light, W. R., & Olson, J. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55443-0 · Cited by 100
Role of the Ferroportin Iron-Responsive Element in Iron and Nitric Oxide Dependent Gene Regulation
Liu, X., Hill, P., & Haile, D. J. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0572 · Cited by 100
The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1)
McKie, A. T., & Barlow, D. J. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-003-1102-3 · Cited by 89
The anemia of chronic disease.
Lee, G. R. (1983) · PubMed · Cited by 70
Some Factors Affecting the Release of Iron from Reticuloendothelial Cells
Lipschitz, D. A., Simon, M., Lynch, S. R., Dugard, J., Bothwell, T. H., & Charlton, R. W. (1971) · British Journal of Haematology · doi:10.1111/j.1365-2141.1971.tb03441.x · Cited by 67
Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux
Chung, J., Haile, D. J., & Wessling‐Resnick, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306622101 · Cited by 56
Self-citationHuman macrophage hemoglobin‐iron metabolism in vitro
Custer, G., Balcerzak, S. P., & Rinehart, J. J. (1982) · American Journal of Hematology · doi:10.1002/ajh.2830130105 · Cited by 56
Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages
Birgegård, G., & Caro, J. (1984) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1984.tb02208.x · Cited by 44
Gallì, A., Bergamaschi, G., Recalde, H. R., Biasiotto, G., Santambrogio, P., Boggi, S., Levi, S., Arosio, P., & Cazzola, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05238.x · Cited by 32
Erythrocyte Catabolism in the Inflammatory Peritoneal Monocyte
Kleber, E. E., Lynch, S. R., SKIKNE, B. S., Torrance, J. D., Bothwell, T. H., & Charlton, R. W. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb07126.x · Cited by 19
In vitro behavior of stem cells.
Krantz, S. B., & Fried, W. I. (1968) · PubMed · Cited by 15
Iron Compounds after Erythrophagocytosis: Chemical Characterization and Immunomodulatory Effects
Costa, L. M. G., Moura, E., Moura, J. J. G., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8667 · Cited by 11
Research works printed but not linked: 3
- Krantz, S. B. & Fried, W. (1968) J. Lab. Clin. Med. 72, 157-164.5659540
- Lee, G. R. (1983) Semin. Hematol. 20, 61-80.6348957
- Konijn, A. M. & Hershko, C. (1977) Br. J. Haematol. 37, 7-16.588480 · doi:10.1111/j.1365-2141.1977.tb08806.x · Paper page
Cited by
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Metal homeostasis and resistance in bacteria
Chandrangsu, P., Rensing, C., & Helmann, J. D. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.15 · Cited by 812
BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism
Andriopoulos Jr, B., Corradini, E., Xia, Y., Faasse, S. A., Chen, S., Grgurevic, L., Knutson, M. D., Pietrangelo, A., Vukicevic, S., Lin, H. Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.335 · Cited by 769
Self-citationRegulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Metadata
- Authors
- Knutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M.
- Affiliations
- Harvard University (US)
- Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 32611; and Departments of Immunology and Infectious Diseases and Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115
- ORCID
- Knutson, Mitchell D.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-01-21
- Volume
- 102
- Issue
- 5
- Pages
- 1324-1328
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC547844
- OpenAlex
- W2118745767
- Cited by
- 479
- References
- 37
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 22 · 2020: 24 · 2019: 17 · 2018: 17 · 2017: 22 · 2016: 13 · 2015: 21 · 2014: 29 · 2013: 29 · 2012: 27
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- University of California, Los Angeles
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056160, DK56160, DK 065064, K01DK065064)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- ferroportin 1, hepcidin, erythrophagocytosis, macrophages, iron efflux, iron recycling, erythrocyte iron, heme iron, non-heme iron, iron homeostasis, J774 macrophages
- MeSH terms
- Ferroportin, Animals, Cell Line, Erythrocytes, Gene Expression Regulation, Humans, Iron, Macrophages, Phagocytosis, Antimicrobial Cationic Peptides, Cation Transport Proteins, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.